Nucleus Awards
2025 Capital Award
1315 Capital
1315 Capital is a private investment firm with over $1 billion of assets under management that provides growth capital to commercial-stage healthcare services, pharmaceutical & medtech outsourced services, pharmaceutical & medtech products, and health & wellness companies. The firm targets $5 million to $50 million investments in commercial healthcare businesses that have the potential to scale to $50 million to $200 million of revenue, a level they believe is highly attractive for acquisition or to access the public markets. 1315 Capital targets both minority and majority investments in companies where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system. For more information, please visit www.1315capital.com.
Capital Award
This award recognizes an individual or organization that has intentionally sourced and invested in minority-owned startups or founders with the purpose of mobilizing capital to unlock innovation. The Capital awardee is investing in diverse minds to make transformative change in the STEM ecosystem.
2025 capital award sponsor
The Nucleus Awards
Celebrate leaders in our region who convene the community, commercialize promising technology and cultivate the future of STEM, during our biggest night of the year.
